PMC:7787218 / 1167-1329 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7787218","sourcedb":"PMC","sourceid":"7787218","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7787218","text":" saline) and vaccine groups in both trials.1\nThe Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom was the first to authorize emerg","tracks":[]}